Forvard narx/daromad multiplikatori: Actuate Therapeutics Inc. (ACTU)

Actuate Therapeutics Inc. (ACTU) kompaniyasining korporativ logotipi

Actuate Therapeutics, Inc. (ACTU) uchun bozor tendentsiyasi klinik sinovlarning ilk bosqichlaridagi o'ta kuchli tartibga soluvchi xavflar bilan bog'liqdir. GURU.Markets platformasida kompaniyaning kutilayotgan P/S grafigini tahlil qilib, yakuniy metrika ko'rsatkichi ekanligini ko'ramiz. O'sish potentsiali glioblastoma terapiyasi uchun eladrasibning ishga tushirilishiga asoslangan; biroq, daromadning yo'qligi va spekulyativ kapitalga bog'liqlik investorlar uchun sezilarli xatarlarni yuzaga keltirmoqda.

ACTU (actuatetherapeutics.com) Forvard P/S multiplikatori tarixi 04.07.2022dan 16.11.2026gacha

Actuate Therapeutics, Inc. (ACTU) kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning dastlabki tahlili:Actuate Therapeutics, Inc (ACTU)
Actuate Therapeutics Inc tomonidan chiqariladigan mahsulotlar

Actuate Therapeutics, Inc. (ACTU) uchun xavfsizlik zaxirasi bahosi bozor qiymatining kutilayotgan yillik savdo hajmi nisbatiga asoslangan bo'lib, u hozirda ni tashkil etadi. Forward P/S ko'rsatkichi tahlili orqali investor kapitalizatsiyaning tushum prognozlariga nisbatan haddan tashqari baholanganlik darajasini aniqlaydi, bu esa metastatik saratonning chidamli shakllari bilan kurashish uchun innovatsion GSK-3 beta inhibitorlarini ishlab chiqayotgan biofarmatsevtika kompaniyasi uchun o'ta muhimdir.

Muhim raqobatchilar

Forvard P/S multiplikatori ONC (BeiGene Oncology)|Forvard P/S multiplikatori Halozyme Corp HALO|RVMD: Forvard narx/daromad multiplikatori|Ascentage Pharma Group (AAPG) - Forvard narx/daromad multiplikatori|CG Oncology Therapeutics (CGON) - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati UroGen Pharma URGN|Narxning prognoz qilingan daromadga nisbati Bicara Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Personalis Genomics PSNL|Forvard P/S multiplikatori ERAS|Narxning kutilayotgan daromadga nisbati DCTH|Y-mAbs Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Aura Biosciences Inc (AURA)|CADL: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ARAY (Accuray Inc.)|SLS: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati CTOR|Narxning prognoz qilingan daromadga nisbati TuHURA Biosciences Inc.|TARA: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Fate Therapeutics (FATE)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Aadi Bioscience|Narxning prognoz qilingan daromadga nisbati TScan Therapeutics Inc TCRX|CSBR: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|XBIT: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx CVM (cel-sci.com)|OSTX: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Radiopharm Theranostics Ltd (RADX)|ARTV (Artiva) - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ANL (Adlai Nortye)|Narxning prognoz qilingan daromadga nisbati Veru Pharma (VERU)|Forvard P/S multiplikatori Tempest Tx (TPST)|Narxning prognoz qilingan daromadga nisbati xiliotx.com XLO|Enochian BioSciences - Narxning prognoz qilingan daromadga nisbati|Mural Oncology - Forvard P/S multiplikatori|KAPA - Forvard P/S multiplikatori|OnKure Therapeutics Inc (OKUR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori CytoMed|Narxning prognoz qilingan daromadga nisbati curis.com|Forvard narx/daromad multiplikatori Apollomics, Inc. (APLM)|Forvard P/S multiplikatori THAR|Advanced Biomed Corp - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Genprex GNPX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Calidi Bio (CLDI)|sunshinebiopharma.com - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati xeneticbio.com|salariuspharma.com (SLRX) - Narxning prognoz qilingan daromadga nisbati|Purple Biotech Ltd. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati AON|Forvard P/S multiplikatori BeiGene Ltd.|Narxning prognoz qilingan daromadga nisbati Checkpoint Therapeutics, Inc. (CKPT)|Forvard narx/daromad multiplikatori Elevation Oncology, Inc. ELEV|Forvard P/S multiplikatori ICAD (iCAD Inc.)|IKNA - Forvard narx/daromad multiplikatori|NTBL: Forvard narx/daromad multiplikatori|viracta.com (VIRX) - Forvard narx/daromad multiplikatori|MorphoSys (MOR) - Narxning prognoz qilingan daromadga nisbati|NAYA Biosciences Corp (NAYA) - Forvard P/S multiplikatori|AAPGV (Ascentage) - Forvard P/S multiplikatori